| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | Director | Former Director
3 companies
Boyce Sarah is a President And CEO at Avidity Biosciences, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 1 sell.
Estimated insider holdings value: $4.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2022 | RNA Avidity Biosciences, Inc. | President And CEO | Sale+OE | 100 | $22.47 | $2,247.00 | -100% |